Yiannou P - Search Results

1

The impact of programmed cell death-ligand 1 (PD-L1) and CD8 expression in grade 3 endometrial carcinomas.

Vagios S, Yiannou P, Giannikaki E, Doulgeraki T, Papadimitriou C, Rodolakis A, Nonni A, Vlachos A, Pavlakis K. Vagios S, et al. Among authors: yiannou p. Int J Clin Oncol. 2019 Nov;24(11):1419-1428. doi: 10.1007/s10147-019-01484-0. Epub 2019 Jun 13. Int J Clin Oncol. 2019. PMID: 31197557

2

Mismatch repair status in high-grade endometrial carcinomas of endometrioid and non-endometrioid type.

Doulgeraki T, Vagios S, Kavoura E, Yiannou P, Messini I, Nonni A, Papadimitriou C, Vlachos A, Pavlakis K. Doulgeraki T, et al. Among authors: yiannou p. J BUON. 2019 Sep-Oct;24(5):2020-2027. J BUON. 2019. PMID: 31786870 Free article.

3

Tumor dissemination after laparoscopic surgery for an unsuspected endometrial stromal tumor.

Pavlakis K, Messini I, Papadimitriou CA, Zagouri F, Yiannou P, Mavrelos D, Panoskaltis T. Pavlakis K, et al. Among authors: yiannou p. Eur J Gynaecol Oncol. 2011;32(3):362-3. Eur J Gynaecol Oncol. 2011. PMID: 21797138

4

PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma.

Pavlakis K, Messini I, Vrekoussis T, Panoskaltsis T, Chrissanthakis D, Yiannou P, Stathopoulos EN. Pavlakis K, et al. Among authors: yiannou p. Gynecol Oncol. 2010 Dec;119(3):516-9. doi: 10.1016/j.ygyno.2010.08.023. Epub 2010 Sep 15. Gynecol Oncol. 2010. PMID: 20833413

5

Claudin-3 and claudin-4: distinct prognostic significance in triple-negative and luminal breast cancer.

Kolokytha P, Yiannou P, Keramopoulos D, Kolokythas A, Nonni A, Patsouris E, Pavlakis K. Kolokytha P, et al. Among authors: yiannou p. Appl Immunohistochem Mol Morphol. 2014;22(2):125-31. doi: 10.1097/PAI.0b013e31828d9d62. Appl Immunohistochem Mol Morphol. 2014. PMID: 23702644

6

Identifiable Risk Factors for Lymph Node Metastases in Grade 1 Endometrial Carcinoma.

Pavlakis K, Rodolakis A, Vagios S, Voulgaris Z, Messini I, Yiannou P, Vlachos A, Panoskaltsis T. Pavlakis K, et al. Among authors: yiannou p. Int J Gynecol Cancer. 2017 Oct;27(8):1694-1700. doi: 10.1097/IGC.0000000000001070. Int J Gynecol Cancer. 2017. PMID: 28786874

7

Assessing the landscape of ovarian serous borderline tumors.

Messini I, Doulgeraki T, Chrysanthakis D, Yiannou P, Gavresea T, Papadimitriou C, Panoskaltsis T, Voulgaris Z, Vlachos A, Pavlakis K. Messini I, et al. Among authors: yiannou p. Int J Gynecol Cancer. 2019 Mar;29(3):572-578. doi: 10.1136/ijgc-2018-000086. Epub 2019 Jan 18. Int J Gynecol Cancer. 2019. PMID: 30659030

8

Mucinous epithelial lesions in endometrial curettage material: a diagnostic challenge.

Pavlakis K, Vrekoussis T, Messini I, Voulgaris Z, Chrysanthakis D, Yiannou P, Stofas A, Panoskaltsis T. Pavlakis K, et al. Among authors: yiannou p. Appl Immunohistochem Mol Morphol. 2012 Dec;20(6):607-13. doi: 10.1097/PAI.0b013e31825251a4. Appl Immunohistochem Mol Morphol. 2012. PMID: 22531687

9

Prevalence of HPV genotypes in cervical adenocarcinoma: a study in Greek women.

Chrysagi A, Kaparos G, Vrekoussis T, Yiannou P, Messini I, Patsouris E, Pavlakis K. Chrysagi A, et al. Among authors: yiannou p. J BUON. 2016 May-Jun;21(3):666-72. J BUON. 2016. PMID: 27569088 Free article.

10

MELF invasion in endometrial cancer as a risk factor for lymph node metastasis.

Pavlakis K, Messini I, Vrekoussis T, Panoskaltsis T, Chrysanthakis D, Yiannou P, Voulgaris Z. Pavlakis K, et al. Among authors: yiannou p. Histopathology. 2011 May;58(6):966-73. doi: 10.1111/j.1365-2559.2011.03802.x. Epub 2011 Mar 25. Histopathology. 2011. PMID: 21438907

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters